Neil F. McFarlane - 13 Feb 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
Issuer symbol
ZVRA
Transactions as of
13 Feb 2025
Net transactions value
-$727,390
Form type
4
Filing time
14 Feb 2025, 17:54:04 UTC
Previous filing
10 Feb 2025
Next filing
10 Oct 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Sale $481,428 -61,273 -22% $7.86 222,060 13 Feb 2025 Direct F1
transaction ZVRA Common Stock Sale $245,962 -30,544 -14% $8.05 191,516 14 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Adoption date of referenced 10b5-1(c) plan is: 10-15-2024